Gregory Ferenstein
Gregory Ferenstein is a senior fellow in drug policy at Reason Foundation.
-
Psilocybin access would improve mental health care in Massachusetts
Ballot Question 4 would create a regulated framework for legal, professionally facilitated psychedelic services and therapy.
-
State psychedelics legalization and policy roundup — September 2024
A Massachusetts ballot initiative moves forward, Colorado considers high business application and renewal fees, and more.
-
State psychedelics legalization and policy roundup — July 2024
Psychedelics on the ballot in Massachusetts, Colorado proposes new regulatory rules, and Arizona Gov. Hobbs vetoes a psychedelics bill.
-
A glimpse into Colorado’s emerging legal pyschedelics scene
Colorado became the first state in America where residents can legally grow and share psilocybin mushrooms in 2022.
-
How the FDA can safely approve a promising but controversial mental health drug
The FDA’s existing processes may be able to address the advisory committee’s worries about the previous tests.
-
States can legalize MDMA for pharmaceutical use even if the federal government does not
States have many options when considering the legalization or decriminalization of psychedelic medicines within their borders.
-
State psychedelics legalization and policy roundup — May 2024
Legislative progress slows, a Massachusetts ballot initiative moves forward, and Colorado rejects censorship.
-
Assessing Michigan voters’ support for legalizing psychedelic therapy
An online survey finds 65% of registered voters in Michigan say they support allowing licensed health professionals to legally prescribe psychedelics.
-
California should legalize psychedelics and learn from its marijuana regulation mistakes
The state’s high cannabis taxes and burdensome regulations make legal marijuana products expensive and keep the illicit market thriving.
-
Massachusetts should allow psychedelic therapy
A Massachusetts ballot initiative would create a regulated framework for legal, professionally facilitated psychedelic services and therapy.
-
Colorado’s rejection of Senate Bill 24-158 is good for privacy, free speech
For now, the defeat of Colorado Senate Bill 24-158 was a win for consumers, privacy and free speech.
-
State psychedelics legalization and policy roundup — March 2024
The current state proposals fall into a few broad categories, primarily regulated access and decriminalization of psychedelics.
-
Massachusetts ballot initiative aims to legalize psychedelics
The initiative would legalize guided in-person psychedelic experiences and allow people to grow and consume psychedelics for spiritual or mental health purposes.
-
Nonprofit announces new partnership with Ohio to tackle opioid addiction with ibogaine
A promising new partnership announced in Ohio this week will explore the use of the psychedelic compound ibogaine to treat opioid use disorder.
-
State psychedelics policy roundup: January 2024 edition
New Hampshire proposes retail sales, Colorado considers ways to lower costs of professional services, and more.
-
New Hampshire proposes a unique approach to medical psychedelics
House Bill 1693 would allow qualified individuals to purchase and consume LSD, mescaline, and psilocybin.
-
New study of psychedelic ibogaine could motivate policy reforms
A recent study could help remove barriers to the development of ibogaine as a promising treatment for opioid addiction.
-
State psychedelics policy roundup: November 2023 edition
Proposed psychedelics legalization in Massachusetts, Colorado considers cost-effective regulations, Kentucky's ibogaine debate and more.